DEMENTIA MODERATE
Clinical trials for DEMENTIA MODERATE explained in plain language.
Never miss a new study
Get alerted when new DEMENTIA MODERATE trials appear
Sign up with your email to follow new studies for DEMENTIA MODERATE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a daily light-and-sound session help slow Alzheimer's?
Disease control OngoingThis study tests whether a device that delivers light and sound stimulation for 60 minutes each day can slow the decline in memory and daily living skills in people with mild to moderate Alzheimer's disease. About 670 participants will use either the active device or a sham (inac…
Matched conditions: DEMENTIA MODERATE
Phase: NA • Sponsor: Cognito Therapeutics, Inc. • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New pill aims to slow Alzheimer's decline in major trial
Disease control OngoingThis study tests whether a daily pill called Xanamem can safely help people with mild or moderate Alzheimer's dementia. About 247 adults aged 50 and older will receive either Xanamem or a placebo for 36 weeks, with an option to continue treatment for up to 108 weeks. The goal is …
Matched conditions: DEMENTIA MODERATE
Phase: PHASE2, PHASE3 • Sponsor: Actinogen Medical • Aim: Disease control
Last updated May 15, 2026 11:54 UTC